Correlation Between Mereo Biopharma and Trinity Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo Biopharma and Trinity Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo Biopharma and Trinity Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo Biopharma Group and Trinity Bio ADR, you can compare the effects of market volatilities on Mereo Biopharma and Trinity Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo Biopharma with a short position of Trinity Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo Biopharma and Trinity Bio.

Diversification Opportunities for Mereo Biopharma and Trinity Bio

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Mereo and Trinity is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Mereo Biopharma Group and Trinity Bio ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trinity Bio ADR and Mereo Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo Biopharma Group are associated (or correlated) with Trinity Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trinity Bio ADR has no effect on the direction of Mereo Biopharma i.e., Mereo Biopharma and Trinity Bio go up and down completely randomly.

Pair Corralation between Mereo Biopharma and Trinity Bio

Given the investment horizon of 90 days Mereo Biopharma Group is expected to generate 1.91 times more return on investment than Trinity Bio. However, Mereo Biopharma is 1.91 times more volatile than Trinity Bio ADR. It trades about 0.0 of its potential returns per unit of risk. Trinity Bio ADR is currently generating about -0.03 per unit of risk. If you would invest  286.00  in Mereo Biopharma Group on May 9, 2022 and sell it today you would lose (157.00)  from holding Mereo Biopharma Group or give up 54.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.63%
ValuesDaily Returns

Mereo Biopharma Group  vs.  Trinity Bio ADR

 Performance (%) 
       Timeline  
Mereo Biopharma Group 
Mereo Performance
15 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Mereo Biopharma Group are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting technical and fundamental indicators, Mereo Biopharma disclosed solid returns over the last few months and may actually be approaching a breakup point.

Mereo Price Channel

Trinity Bio ADR 
Trinity Performance
8 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Trinity Bio ADR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady forward indicators, Trinity Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Trinity Price Channel

Mereo Biopharma and Trinity Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo Biopharma and Trinity Bio

The main advantage of trading using opposite Mereo Biopharma and Trinity Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo Biopharma position performs unexpectedly, Trinity Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trinity Bio will offset losses from the drop in Trinity Bio's long position.

Mereo Biopharma Group

Pair trading matchups for Mereo Biopharma

The idea behind Mereo Biopharma Group and Trinity Bio ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go